# Sickle Cell Disease Conditioning for Bone Marrow Transplant

> **NCT00968162** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 8 (actual)

## Conditions studied

- Bone Marrow Transplantation
- Sickle Cell Disease

## Interventions

- **DRUG:** fludarabine

## Key facts

- **NCT ID:** NCT00968162
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2014-03
- **Final completion:** 2016-01-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968162, "Sickle Cell Disease Conditioning for Bone Marrow Transplant". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00968162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*